SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000769993-24-000277
Filing Date
2024-06-21
Accepted
2024-06-21 16:52:23
Documents
1
Group Members
GSCO

Document Format Files

Seq Description Document Type Size
1 RAPPORT.txt SC 13G 47206
  Complete submission text file 0000769993-24-000277.txt   48973
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

IRS No.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Subject) CIK: 0002012593 (see all company filings)

IRS No.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94532 | Film No.: 241061157
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)